Best Real Estate Podcasts 2026

All-In with Chamath, Jason, Sacks & Friedberg

All-In Podcast, LLC

2x/week

Four tech billionaires debate markets, politics, and science with zero filter. The most influential group chat in Silicon Valley, now public.

→ WHAT IT COVERS XAI leases Colossus 1 data center to Anthropic, adding 220,000 NVIDIA GPUs as Anthropic grows from $10B to $44B ARR in four months. T

Odd Lots

Daily

Bloomberg's Joe Weisenthal and Tracy Alloway explore the weird, wonderful corners of markets and economics that mainstream finance media ignores.

→ WHAT IT COVERS Mariana Mazzucato, economist and UCL professor, argues that effective government requires mission-oriented thinking — defining concre

Invest Like the Best with Patrick O'Shaughnessy

Colossus | Investing & Business Podcasts

Weekly

Patrick O'Shaughnessy interviews the world's best investors and operators. Deep, patient conversations you won't find anywhere else in finance media.

→ WHAT IT COVERS Airbnb cofounder Brian Chesky traces his path from industrial design training at RISD through the pandemic crisis that forced him int

Citeline Podcasts

Daily

Industry intelligence on clinical trials, regulatory trends, and pharma strategy from Citeline's expert analysts.

→ WHAT IT COVERS Generics Bulletin editors report from two February 2026 industry conferences — AAM's Access meeting in Miami and Medicines for Europe

20VC (20 Minute VC)

3x/week

Harry Stebbings interviews the biggest names in venture capital — 20 minutes, no filler. The most connected VC pod in the ecosystem.

→ WHAT IT COVERS Harry Stebbings, Rory O'Driscoll, and Jason Lemkin analyze Mag7 earnings week — Alphabet and Amazon outperform while Microsoft stagna

Investing for Beginners

3x/week

Andrew Sather and Dave Ahern teach investing from scratch — stock analysis, value investing, and portfolio building for complete beginners.

→ WHAT IT COVERS Stephen Morris and Andrew Sather break down the circle of competence framework for stock picking — defining it as knowing both what y

Stacking Benjamins

3x/week

Joe Saul-Sehy and his team make personal finance entertaining and approachable. Practical money advice served with genuine humor.

→ WHAT IT COVERS Amy Minkley, host of the Financial Independence Freedom Retreat in Bali, joins Stacking Benjamins to discuss how the FIRE movement ha

In Good Company with Nicolai Tangen

2x/week

The CEO of Norway's $1.7 trillion sovereign wealth fund interviews the world's top business leaders. Unmatched access, understated brilliance.

→ WHAT IT COVERS Arvind Krishna, chairman and CEO of IBM, explains how he repositioned IBM as a hybrid cloud and AI company since 2020, why AI rivals

Bankless

3x/week

Ryan Sean Adams and David Hoffman explore crypto, Ethereum, and DeFi with depth and conviction. The intellectual home of the Ethereum community.

→ WHAT IT COVERS Geopolitical analyst Kamran Bokhari explains the strategic logic behind the U.S.-Iran war as part of a broader American grand strateg

This Week in Startups

3x/week

Jason Calacanis covers startup news, interviews founders, and shares unfiltered opinions on tech and investing. The OG startup podcast.

→ WHAT IT COVERS GoAbacus founder David Moscatelli presents on-premise AI hardware for regulated industries, Variana's tackles human identity verifica

We Study Billionaires

2x/week

Warren Buffett-style investing education. Stig and Preston break down the strategies of legendary investors with clarity and intellectual honesty.

→ WHAT IT COVERS Daniel Mahncke and Shawn O'Malley analyze whether Microsoft, trading at a forward PE of 20x after a 35% six-month selloff, represents

Beyond Biotech

Weekly

Labiotech.eu's official podcast — broad global coverage of biotech news, partnerships, and emerging therapies. Great for a European perspective on drug development.

→ WHAT IT COVERS Ryan Cavewood, CEO of Labthread, draws on a decade running Oxgene (acquired by Wuxi Advanced Therapies in 2021) to explain how fragme

So Money with Farnoosh Torabi

3x/week

Farnoosh Torabi covers money, career, and life with a blend of expert interviews and listener Q&A. Approachable, smart personal finance.

→ WHAT IT COVERS Nikki Mamano, author of memoir Breaking Good , recounts her path from teenage trauma and addiction to running a drug operation in Ha

BiggerPockets Real Estate Podcast

BiggerPockets

3x/week

Dave Meyer and the BiggerPockets team share real strategies from real estate investors building wealth right now. The largest RE investing community's flagship show.

→ WHAT IT COVERS Grace Guttenkopf and Amelia Magee, Iowa-based investors with 25–40 doors each, share five lessons from five years of real estate inve

The Money Guy Show

3x/week

Brian Preston and Bo Hanson help everyday Americans build wealth with practical financial planning. Approachable, systematic, and trustworthy.

→ WHAT IT COVERS Brian Preston and Bo Hansen evaluate car brands using a "cruise or snooze" framework, revealing which vehicles destroy wealth versus

Biotech Hangout

Weekly

Friday roundtable with Daphne Zohar, Brad Loncar, and rotating guests. Fast-paced weekly recap of biotech news, deals, and FDA actions — like a biotech happy hour with insiders.

→ WHAT IT COVERS Biotech Hangout Episode 182 covers a record-breaking Q1 2026 secondary offering environment, three new M&A deals totaling over $6 bil

What Bitcoin Did

2x/week

Peter McCormack interviews Bitcoin builders, economists, and skeptics. Balanced, curious, and the most respected Bitcoin-focused podcast.

→ WHAT IT COVERS Peter McCormack and academic Neema Parvini examine why populist movements like Trump's MAGA and UK Reform consistently fail to delive

The Compound and Friends

2x/week

Investing podcast with Downtown Josh Brown, Michael Batnick, and rotating guests for expert insight and hot takes on business and investing.

Masters in Business

2x/week

Bloomberg's Barry Ritholtz interviews the biggest names in finance and investing. Long-running, consistently excellent, and refreshingly direct.

→ WHAT IT COVERS Francine Lacqua, award-winning journalist with 25 years interviewing global leaders, launches the podcast version of Leaders, explori

BiggerPockets Money Podcast

BiggerPockets

2x/week

Mindy Jensen and Scott Trench go beyond budgeting basics into real estate investing, side income, and FIRE strategies for the financially ambitious.

→ WHAT IT COVERS Mindy Jensen and Scott Trench identify 13 financial independence mistakes split into 5 obvious errors and 8 subtle ones, covering com

Business Breakdowns

Biweekly

Colossus analysts reverse-engineer what makes great businesses tick. Like getting an MBA case study every week, but from practitioners, not professors.

→ WHAT IT COVERS Opendoor CEO Kaz Najashin joins Business Breakdowns post-Q1 2026 earnings to explain how the company operates as a real estate market

Afford Anything

2x/week

Paula Pant teaches that you can afford anything but not everything. Practical personal finance with an emphasis on intentional spending.

→ WHAT IT COVERS Paula Pant and Joe Saul-Sehy answer three listener questions: whether a dual-income federal employee couple earning $325K should paus

Animal Spirits

2x/week

Ben Carlson and Michael Batnick discuss markets, investing, and the economy with humor and humility. No pretense, just smart takes.

→ WHAT IT COVERS Ben Carlson and Michael Batnick analyze oil markets amid Middle East conflict, debating whether current conditions mirror February 20

The Full Ratchet

2x/week

Nick Moran covers VC deal mechanics, startup metrics, and fund management with rare transparency. A masterclass in venture investing.

→ WHAT IT COVERS David Ulevitch, General Partner at Andreessen Horowitz leading the $1.8B American Dynamism fund, covers investing in defense, energy,

The James Altucher Show

Weekly

James Altucher's wide-ranging interviews span investing, entrepreneurship, and personal reinvention. Unpredictable and always thought-provoking.

→ WHAT IT COVERS Six-time USA Memory Champion Nelson Dellis joins James Altucher to discuss his book Everyday Genius , covering memory palace techniq

The Long Run with Luke Timmerman

Biweekly

Veteran biotech journalist Luke Timmerman goes deep with CEOs, VCs, and scientists. Thoughtful long-form interviews that reveal the people and strategies behind biotech companies.

→ WHAT IT COVERS Richard Pops, 35-year CEO of Alkermes, discusses the company's late-stage development of elixirexant, an orexin-2 receptor agonist ta

Alt Goes Mainstream

Weekly

Robert Picard explores how alternative investments and private markets are going mainstream. WealthTech, secondaries, and the democratization of alts.

→ WHAT IT COVERS EQT Deputy Managing Partner Lennart Blecher traces the evolution of infrastructure investing from core asset ownership to active oper

Venture Stories

Weekly

Village Global's interviews with founders, VCs, and startup operators. Pattern recognition from across the venture ecosystem.

→ WHAT IT COVERS Sumeet Singh of Worldbuild presents the Model Economy framework, arguing that AI scaling laws will eliminate most specialist SaaS-sty

Capital Allocators

Weekly

Ted Seides interviews the world's top institutional investors — endowments, pensions, and sovereign wealth funds. The allocator's allocator podcast.

→ WHAT IT COVERS Will Guidara, co-owner of Eleven Madison Park when it ranked number one in the world, explains how businesses can systematize excepti

Macro Voices

Weekly

Weekly market commentary by hedge fund manager Erik Townsend with interviews from the brightest minds in finance and macroeconomics.

Rational Reminder

Weekly

Ben Felix and Cameron Passmore bring academic finance research to retail investors. Evidence-based investing with intellectual rigor.

→ WHAT IT COVERS Recorded at the New York Stock Exchange for a Vanguard/S&P event marking 50 years of retail index investing, Ben Felix moderates a pa

The Bio Report

Weekly

Award-winning biotech journalist Daniel Levine covers where biotechnology meets business, policy, and science. Concise, well-researched episodes for busy professionals.

→ WHAT IT COVERS Immuneering CEO Ben Zeskind explains how the company's informatics-driven "deep cyclic inhibition" approach to MEK inhibition deliver

BioCentury This Week

Weekly

The gold standard for weekly biotech industry analysis. BioCentury's editorial team breaks down deals, clinical data, and regulatory moves with investor-grade rigor.

→ WHAT IT COVERS BioCentury This Week examines biotech capital markets momentum amid geopolitical uncertainty, Xenon Pharmaceuticals' phase three epil

Her First $100K

Weekly

Tori Dunlap makes financial empowerment accessible and unapologetic. Personal finance and investing advice built for women building wealth.

→ WHAT IT COVERS Erin Gallagher, CEO of Hype Woman and author of the book Hype Woman , walks through her framework for breaking patriarchal self-aban

Business Of Biotech

Weekly

Ben Comer (Life Science Leader) interviews biotech CEOs on the operational realities of building a drug company — from fundraising to commercialization.

→ WHAT IT COVERS Marc Hedrick, CEO of Plus Therapeutics, details the development of Rhenium-186 radiotherapeutic Rayovik for CNS cancers including gli

ChooseFI

Weekly

Brad Barrett and Jonathan Mendonsa built the financial independence community. Practical FIRE movement strategies for real families.

→ WHAT IT COVERS Recorded live at a 115-person "Extraordinary Life" event in Richmond, Virginia on February 15, Alan Donegan, Katie Donegan, and Brad

Hidden Forces

Weekly

Demetri Kofinas explores the unseen forces driving change in markets, technology, and geopolitics. Deep, contrarian, and intellectually fearless.

→ WHAT IT COVERS Iranian scholar Hamidreza Azizi analyzes the US-Israeli military campaign against Iran through week three, examining divergent Americ

The Meb Faber Show

Weekly

Meb Faber covers quantitative investing, asset allocation, and global markets with data-driven clarity. The quant investor's podcast.

→ WHAT IT COVERS Wes Gray and tax analyst Brent Sullivan join Meb Faber to examine IRC Section 351 ETF seeding strategies, the IRS scrutiny targeting

Biotech Bulls & Breakthroughs

Biweekly

Focused on small-cap and mid-cap biotech catalysts — phase 3 data readouts, FDA decisions, and the binary events that move stocks. Essential for biotech investors.

→ WHAT IT COVERS Biotech trader Chef Station and BioPharm Catalyst's John Galliano review mid-2026 catalysts across 15+ small-cap biotech stocks, cove

The Money Mondays

Biweekly

Dan Fleyshman hosts fast-paced conversations about making money, investing, and building businesses. Entrepreneurial energy in every episode.

→ WHAT IT COVERS Garrett White, founder of Wake Up Warrior with 90,000 clients trained, breaks down the three-stage psychological barrier men face aro

The RTW Podcast

Monthly

Real-time commentary on biotech investing trends, clinical data readouts, and sector dynamics from an investment research perspective.

→ WHAT IT COVERS Rod Wong, founder and CIO of RTW Investments, traces biotech's evolution from the 2000 Human Genome Project through today's commercia

Biotech 2050 Podcast

Biweekly

Forward-looking conversations on where biotech is headed — gene therapy, synthetic biology, and the next-gen platform technologies reshaping drug discovery.

→ WHAT IT COVERS Adial Pharmaceuticals CEO Cary Claiborne explains how AD04, a repurposed low-dose ondansetron, targets a specific genetic biomarker f

The Pitch

Biweekly

Real founders pitch real investors, and you hear every question, objection, and negotiation. The most authentic view into early-stage fundraising.

→ WHAT IT COVERS Three pre-seed founders pitch three VCs live in New York City with only 15 minutes each — half the usual 45-minute format. Uche AI (c

BG2Pod with Brad Gerstner and Bill Gurley

Brad Gerstner & Bill Gurley

Monthly

Brad Gerstner and Bill Gurley — two of tech's sharpest investors — debate markets, startups, and capitalism. Rare public conversations between elite VCs.

→ WHAT IT COVERS Nick Turley, Head of Product at ChatGPT, covers how OpenAI scaled from a demo to 900 million weekly active users, the one-third frame

Pathfinders in Biopharma

Biopharma leaders share how they navigated the path from discovery to commercialization. Hard-won lessons from drug development veterans.

→ WHAT IT COVERS RBC Capital Markets analyst Brian Abrams assesses biotech's 80% rally from April 2025 lows, evaluating whether sector momentum can pe

Grant's Current Yield Podcast

James Grant's institutional-grade analysis of interest rates, credit markets, and fixed income. Essential for serious bond investors.

→ WHAT IT COVERS Dan Zwirn of Arena Investors explains how monetary and fiscal policy since 2013 created massive asset bubbles now slowly deflating th

All the Credit

PGIM Fixed Income analysts break down global credit markets, rates, and macro trends. Institutional-grade fixed income intelligence.

→ WHAT IT COVERS PGIM's Greg Peters and Tom McCartan explain how to construct portfolios combining public and private credit assets. They address chal